MFDS — authorised 22 December 2021
- Marketing authorisation holder: NOVARTIS PHARMS CORP
- Status: likely_approved
🇰🇷 Leqvio in South Korea
MFDS authorised Leqvio on 22 December 2021
Marketing authorisation
Leqvio in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in South Korea
Frequently asked questions
Is Leqvio approved in South Korea?
Yes. MFDS authorised it on 22 December 2021.
Who is the marketing authorisation holder for Leqvio in South Korea?
NOVARTIS PHARMS CORP holds the South Korean marketing authorisation.